Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load
Condition: Systemic Amyloidosis Intervention: Drug: Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01) Sponsor: University of Tennessee Graduate School of Medicine Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials